Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Short term Debt: 2021-2024

Historic Short term Debt for Abivax (ABVX) over the last 4 years, with Dec 2024 value amounting to $48.6 million.

  • Abivax's Short term Debt rose 19.49% to $48.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $48.0 million, marking a year-over-year increase of 19.49%. This contributed to the annual value of $48.6 million for FY2024, which is 20.38% up from last year.
  • Abivax's Short term Debt amounted to $48.6 million in FY2024, which was up 20.38% from $40.4 million recorded in FY2023.
  • In the past 5 years, Abivax's Short term Debt registered a high of $48.6 million during FY2024, and its lowest value of $13.4 million during FY2021.
  • Its 3-year average for Short term Debt is $41.5 million, with a median of $40.4 million in 2023.
  • Data for Abivax's Short term Debt shows a peak YoY skyrocketed of 163.42% (in 2022) over the last 5 years.
  • Over the past 4 years, Abivax's Short term Debt (Yearly) stood at $13.4 million in 2021, then soared by 163.42% to $35.4 million in 2022, then climbed by 14.24% to $40.4 million in 2023, then rose by 20.38% to $48.6 million in 2024.